Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Ccl20em1/Cya
Common Name:
Ccl20-KO
Product ID:
S-KO-04226
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Ccl20-KO
Strain ID
KOCMP-20297-Ccl20-B6J-VA
Gene Name
Ccl20
Product ID
S-KO-04226
Gene Alias
CKb4; LARC; MIP-3A; MIP-3[a]; MIP3A; ST38; Scya20; exodus-1
Background
C57BL/6JCya
NCBI ID
20297
Modification
Conventional knockout
Chromosome
1
Phenotype
MGI:1329031
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Ccl20em1/Cya mice (Catalog S-KO-04226) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000113437
NCBI RefSeq
NM_016960.2
Target Region
Exon 2~3
Size of Effective Region
~0.9 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Ccl20, a chemokine, is the only known high-affinity ligand that binds to CCR6, driving the migration of CCR6-expressing cells like B cells, immature dendritic cells, and Th17 cells. It is mainly produced by epithelial cells, and its expression is upregulated under inflammatory conditions. The CCL20-CCR6 axis is involved in autoimmune diseases, cancer progression, and other pathological conditions, making it an important target for research [1,3].

In autoimmune diseases such as inflammatory bowel disease, psoriasis, rheumatoid arthritis, and multiple sclerosis, disrupting the CCR6-CCL20 interaction reduces disease severity, suggesting its key role in these conditions [1]. In colorectal cancer, Fusobacterium nucleatum promotes cancer metastasis through the miR-1322/CCL20 axis and M2 macrophage polarization. Also, CCL20 derived from colorectal cancer cells recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling [2,5]. In preeclampsia, CCL20 is upregulated and may serve as a predictive and diagnostic biomarker [4]. In oral squamous cell carcinoma, salivary CCL20 expression is increased and can be used to differentiate patients from healthy volunteers [6]. In prostate cancer, circSMARCC1 promotes tumor progression by regulating CCL20 via miR-1322 and the CCL20-CCR6 axis affects macrophage infiltration and polarization [7]. In pancreatic cancer, VDR promotes cancer progression by activating CCL20-mediated M2 polarization of tumor-associated macrophages [8].

In conclusion, Ccl20 plays crucial roles in autoimmune diseases and multiple types of cancers. Studies related to Ccl20 in these disease areas, though not specifically from KO/CKO mouse models in the provided references, highlight its significance in disease development and progression. Understanding Ccl20's functions provides potential therapeutic targets for these diseases.

References:

1. Meitei, Heikrujam Thoihen, Jadhav, Nandadeep, Lal, Girdhari. 2021. CCR6-CCL20 axis as a therapeutic target for autoimmune diseases. In Autoimmunity reviews, 20, 102846. doi:10.1016/j.autrev.2021.102846. https://pubmed.ncbi.nlm.nih.gov/33971346/

2. Xu, Chaochao, Fan, Lina, Lin, Yifeng, Si, Jianmin, Chen, Shujie. . Fusobacterium nucleatum promotes colorectal cancer metastasis through miR-1322/CCL20 axis and M2 polarization. In Gut microbes, 13, 1980347. doi:10.1080/19490976.2021.1980347. https://pubmed.ncbi.nlm.nih.gov/34632963/

3. Chen, Weilong, Qin, Yuanyuan, Liu, Suling. . CCL20 Signaling in the Tumor Microenvironment. In Advances in experimental medicine and biology, 1231, 53-65. doi:10.1007/978-3-030-36667-4_6. https://pubmed.ncbi.nlm.nih.gov/32060846/

4. Wang, Xiufang, Yip, Ka Cheuk, He, Andong, Zhang, Qiao, Li, Ruiman. 2022. Plasma Olink Proteomics Identifies CCL20 as a Novel Predictive and Diagnostic Inflammatory Marker for Preeclampsia. In Journal of proteome research, 21, 2998-3006. doi:10.1021/acs.jproteome.2c00544. https://pubmed.ncbi.nlm.nih.gov/36301636/

5. Wang, Dan, Yang, Li, Yu, Weina, Yuan, Weitang, Zhang, Yi. 2019. Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling. In Journal for immunotherapy of cancer, 7, 215. doi:10.1186/s40425-019-0701-2. https://pubmed.ncbi.nlm.nih.gov/31395078/

6. Ueda, Sei, Goto, Mitsuo, Hashimoto, Kengo, Nagao, Toru, Nomoto, Shuji. . Salivary CCL20 Level as a Biomarker for Oral Squamous Cell Carcinoma. In Cancer genomics & proteomics, 18, 103-112. doi:10.21873/cgp.20245. https://pubmed.ncbi.nlm.nih.gov/33608307/

7. Xie, Tao, Fu, Du-Jiang, Li, Zhi-Min, Feng, Ning-Han, Zhao, Shan-Chao. 2022. CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322/CCL20/CCR6 signaling. In Molecular cancer, 21, 173. doi:10.1186/s12943-022-01630-9. https://pubmed.ncbi.nlm.nih.gov/36045408/

8. Li, Hengzhen, Ruan, Yuli, Liu, Chao, Zhang, Yanqiao, Li, Zhiwei. 2024. VDR promotes pancreatic cancer progression in vivo by activating CCL20-mediated M2 polarization of tumor associated macrophage. In Cell communication and signaling : CCS, 22, 224. doi:10.1186/s12964-024-01578-x. https://pubmed.ncbi.nlm.nih.gov/38600588/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest